Supervisor View Full Details

Supervisor View 2
October 3, 2016
Supervisor View Full Details 2nd
October 12, 2016

Prof Dinneen Sean

Organisation:National University of Ireland, Galway


Email AddressEmail hidden; Javascript is required.

Research Fields
  • epidemiology/population health research
  • Other - please suggest keyword(s):
Postgrad Medical Specialites
  • Medicine
  • Surgery
  • General Practice
Medical Subspecialties
  • Clinical Trials
  • Endocrinology
  • Health Informatics
  • Infectious diseases
  • Vascular Medicine
My Work

(1) Exploration of the concept of self-management education and self-management support for people living with type 1 and type 2 diabetes. This work involves active collaboration with Dr Molly Byrne, Health Psychologist and HRB Research Leader, who leads the Health Behaviour Change Research Group in NUI Galway ( Initially our work focused on the evaluation (in Ireland) of structured education programmes like DAFNE (Dose Adjustment for Normal Eating) and DESMOND (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed) for people living with type 1 and type 2 diabetes respectively. More recently we have been working to re-imagine diabetes services for young adults with type 1 diabetes, a group that we (and others) have shown to have very poor outcomes.

(2) Gaining a better understanding of the pathogenesis of the diabetic foot with a view to developing and evaluating new therapies. This work is linked closely to the School of Podiatric Medicine in NUI Galway and involves collaboration with Dr. Aonghus O?Loughlin (Saolta University Health Care Group), Prof. Caroline McIntosh (School of Podiatric Medicine), Dr Georgina Gethin (School of Nursing), Prof Tim O'Brien (Regenerative Medicine Institute) and colleagues in the College of Engineering.

Potential Projects

(1) To explore the role of technology in supporting young adults with type 1 diabetes to live well with their condition
(2) To develop a structured education programme for individuals living with (or at risk from) diabetic foot ulceration (DFU)
(3) To design a protocol for the evaluation of a novel device aimed at reducing the risk of DFU among those at risk
(4) To design and deliver a protocol evaluating the role of glycaemic control as a variable in promoting wound healing in patients with DFU